News & Analysis as of

Non-Compete Agreements › Corporate Practice of Medicine

Non-Compete Agreements are contracts, typically formed in employment or business purchase contexts, where one party agrees to refrain from engaging in a particular line of work or pursuing business within a... more +
Non-Compete Agreements are contracts, typically formed in employment or business purchase contexts, where one party agrees to refrain from engaging in a particular line of work or pursuing business within a certain industry or locale. The purpose of these agreements is to protect employers or business purchasers from competition stemming from former employees or former owners of a business. less -
McDermott Will & Emery

Oregon considers revisions to expansive corporate practice of medicine law

McDermott Will & Emery on

On June 20, 2025, the Oregon legislature passed House Bill (HB) 3410, which amends portions of the corporate practice of medicine law, Senate Bill (SB) 951, enacted on June 9, 2025. As we previously reported, SB 951 prohibits...more

Venable LLP

Oregon Adds Sweeping Restrictions to the Corporate Practice of Medicine Prohibition

Venable LLP on

On June 9, 2025, Oregon Governor Tina Kotek signed S.B. 951 into law (the "Bill"), which significantly limits a common "PC/MSO" model allowing management services organizations (MSO) to provide administrative services to a...more

King & Spalding

Oregon Enacts Further Restrictions Against Private Equity Investment in Medical Practices

King & Spalding on

Last week, Oregon enacted into law SB951, which strengthens Oregon’s corporate practice of medicine doctrine by implementing greater restrictions on arrangements between medical practices and management services organizations...more

Mintz - Health Care Viewpoints

Oregon Law Restricts Common Management Service Organization – Professional Entity Structure

Mintz - Health Care Viewpoints on

On June 9, 2025, Oregon Governor Tina Kotek signed into law Oregon Senate Bill 951 (Oregon CPOM Law), further expanding Oregon’s prohibition on the corporate practice of medicine (CPOM) doctrine. The stated purpose of the...more

Arnall Golden Gregory LLP

New Oregon Law Strengthens Prohibition on the Corporate Practice of Medicine

Arnall Golden Gregory LLP on

On June 9, 2025, Oregon Governor Tina Kotek signed Senate Bill 951 (SB 951) into law. According to sponsors of SB 951, this new legislation is designed to curb the influence of private equity and third-party management...more

Sheppard Mullin Richter & Hampton LLP

Oregon Targets Corporate Practice of Medicine with Enacted Bill: What SB 951 Means for MSOs, PE-Backed Physician Groups, and...

Sheppard Mullin Richter & Hampton LLP on

Overview of SB 951 - Oregon Governor Tina Kotek on Monday, June 9, 2025, signed a first-of-its-kind law that significantly reshapes the state’s regulatory landscape for non-physician investment in medical practices. Senate...more

Foley & Lardner LLP

Oregon’s New Corporate Practice of Medicine Restrictions: Five Takeaways for Digital Health and Telemedicine Companies

Foley & Lardner LLP on

On June 9, 2025, Oregon’s governor signed SB 951 into law, making Oregon one of the most restrictive states in the country with respect to the corporate practice of medicine. This law reflects a growing trend among states to...more

Proskauer - Health Care Law Brief

Oregon Governor Signs S.B. 951, Representing the Nation’s Most Onerous Restriction on the Friendly PC Model

Proskauer - Health Care Law Brief on

Over the past 3 years, as chronicled in several Proskauer alerts, an increasing number of states have sought to regulate physician practice management (“PPM”) and private equity transactions in the health care sector,...more

McGuireWoods LLP

Oregon Enhances Restrictions on Corporate Practice of Medicine

McGuireWoods LLP on

On June 9, 2025, Oregon Senate Bill 951 (SB 951) was officially signed into law, significantly strengthening the state’s prohibition on the corporate practice of medicine. SB 951 restricts how professional medical practices...more

Benesch

Healthcare Private Equity Investment: As Federal Headwinds Subside, a Gale Warning Goes Up in Many States

Benesch on

Private equity (PE) investment in the U.S. healthcare sector faces a complex and evolving regulatory and legislative landscape. Both federal and state authorities are intensifying scrutiny of PE investment, driven by concerns...more

Fenwick & West LLP

Heart of Healthcare Podcast: FTC Chair Lina Khan on Healthcare, Antitrust, and the Future of Competition

Fenwick & West LLP on

In a recent episode of the Heart of Healthcare podcast, co-hosts Michael T. Esquivel and Halle Tecco, sat down with Federal Trade Commission (FTC) Chair Lina Khan, who offered her perspective on the intersection of antitrust...more

Venable LLP

Event in Review: Antitrust in Healthcare: The Good, the Bad, and the Ugly

Venable LLP on

Investment in the healthcare industry requires careful consideration, as it involves numerous distinct areas of the law. Venable's Private Equity Investment in Healthcare webinar series explores the unique issues and timely...more

Benesch

Valuation Trends in Private Equity, Nephrology, Dialysis, Value-Based Care and Outpatient Labs

Benesch on

Valuations, and how a business reacts to them, directly impact a business’s ability to complete successful transactions. In the healthcare sector, compliance with federal and state laws against self-referral and kickbacks and...more

13 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide